FDA Warning Letter — Nipro Renal Soultions USA, Corporation
The FDA took a Warning Letter action against Nipro Renal Soultions USA, Corporation on July 16, 2026 (Lewisberry, PA). The action was issued by CDRH and concerns devices products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Nipro Renal Soultions USA, Corporation
- Date
- July 16, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Center
- CDRH
- Location
- Lewisberry, PA (United States)